Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1976 1
1982 1
1984 3
1985 2
1986 3
1987 3
1988 7
1989 10
1990 5
1991 6
1992 9
1993 7
1994 23
1995 10
1996 19
1997 18
1998 15
1999 25
2000 22
2001 26
2002 21
2003 38
2004 33
2005 29
2006 28
2007 31
2008 31
2009 25
2010 39
2011 31
2012 30
2013 37
2014 26
2015 37
2016 56
2017 41
2018 42
2019 40
2020 31
2021 41
2022 40
2023 50
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

928 results

Results by year

Filters applied: . Clear all
Page 1
Progressive supranuclear palsy: diagnosis and management.
Rowe JB, Holland N, Rittman T. Rowe JB, et al. Pract Neurol. 2021 Oct;21(5):376-383. doi: 10.1136/practneurol-2020-002794. Epub 2021 Jul 2. Pract Neurol. 2021. PMID: 34215700 Free PMC article. Review.
Treating patients with progressive supranuclear palsy (PSP) is both effective and rewarding. ...
Treating patients with progressive supranuclear palsy (PSP) is both effective and rewarding. ...
Progressive supranuclear palsy: Advances in diagnosis and management.
Coughlin DG, Litvan I. Coughlin DG, et al. Parkinsonism Relat Disord. 2020 Apr;73:105-116. doi: 10.1016/j.parkreldis.2020.04.014. Epub 2020 May 25. Parkinsonism Relat Disord. 2020. PMID: 32487421 Free PMC article. Review.
Progressive supranuclear palsy (PSP) is a complex clinicopathologic disease with no current cure or disease modulating therapies that can only be definitively confirmed at autopsy. ...
Progressive supranuclear palsy (PSP) is a complex clinicopathologic disease with no current cure or disease modulating …
Frontotemporal Dementia.
Olney NT, Spina S, Miller BL. Olney NT, et al. Neurol Clin. 2017 May;35(2):339-374. doi: 10.1016/j.ncl.2017.01.008. Neurol Clin. 2017. PMID: 28410663 Free PMC article. Review.
The core FTD spectrum disorders include behavioral variant FTD, nonfluent/agrammatic variant primary progressive aphasia, and semantic variant PPA. Related FTD disorders include frontotemporal dementia with motor neuron disease, progressive supranuclear pa …
The core FTD spectrum disorders include behavioral variant FTD, nonfluent/agrammatic variant primary progressive aphasia, and semanti …
Progressive supranuclear palsy.
Giagkou N, Höglinger GU, Stamelou M. Giagkou N, et al. Int Rev Neurobiol. 2019;149:49-86. doi: 10.1016/bs.irn.2019.10.013. Epub 2019 Nov 21. Int Rev Neurobiol. 2019. PMID: 31779824 Review.
Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized pathologically by 4 repeat tau deposition in various cell types and anatomical regions. Richardson's syndrome (RS) is the initially described and one of the clinical phenotypes …
Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized pathologically by 4 repeat tau deposi …
Progressive Supranuclear Palsy and Corticobasal Syndrome.
Pantelyat A. Pantelyat A. Continuum (Minneap Minn). 2022 Oct 1;28(5):1364-1378. doi: 10.1212/CON.0000000000001158. Continuum (Minneap Minn). 2022. PMID: 36222770 Review.
PURPOSE OF REVIEW: The differential diagnosis of parkinsonism (tremor, rigidity, bradykinesia, and gait difficulty/postural instability) is broad and includes two neurodegenerative conditions that exist on a clinicopathologic spectrum: progressive supranuclear pa …
PURPOSE OF REVIEW: The differential diagnosis of parkinsonism (tremor, rigidity, bradykinesia, and gait difficulty/postural instability) is …
Tauopathies.
Kovacs GG. Kovacs GG. Handb Clin Neurol. 2017;145:355-368. doi: 10.1016/B978-0-12-802395-2.00025-0. Handb Clin Neurol. 2017. PMID: 28987182 Review.
The spectrum of tau pathologies expands beyond the traditionally discussed disease forms like Pick disease, progressive supranuclear palsy, corticobasal degeneration, and argyrophilic grain disease. ...
The spectrum of tau pathologies expands beyond the traditionally discussed disease forms like Pick disease, progressive supranucle …
An Update on Apraxia of Speech.
Utianski RL, Josephs KA. Utianski RL, et al. Curr Neurol Neurosci Rep. 2023 Jul;23(7):353-359. doi: 10.1007/s11910-023-01275-1. Epub 2023 Jun 3. Curr Neurol Neurosci Rep. 2023. PMID: 37269450 Free PMC article. Review.
PURPOSE OF REVIEW: Apraxia of speech (AOS) is a motor speech disorder that has long been recognized to occur secondary to acute neurologic insults and, more recently, to neurodegenerative diseases as a harbinger for progressive supranuclear palsy and corticob …
PURPOSE OF REVIEW: Apraxia of speech (AOS) is a motor speech disorder that has long been recognized to occur secondary to acute neurologic i …
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.
Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU. Boxer AL, et al. Lancet Neurol. 2017 Jul;16(7):552-563. doi: 10.1016/S1474-4422(17)30157-6. Epub 2017 Jun 13. Lancet Neurol. 2017. PMID: 28653647 Free PMC article. Review.
Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinsonism, is now recognised as a range of motor and behavioural syndromes that are associated with a characteristic 4-repeat tau neuropathology. ...
Progressive supranuclear palsy (PSP), previously believed to be a common cause of atypical parkinsonism, is now recogni …
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment.
Veilleux Carpentier A, McFarland NR. Veilleux Carpentier A, et al. Curr Opin Neurol. 2023 Aug 1;36(4):309-316. doi: 10.1097/WCO.0000000000001163. Epub 2023 May 31. Curr Opin Neurol. 2023. PMID: 37381926 Review.
PURPOSE OF REVIEW: Since the original description of progressive supranuclear palsy (PSP) by Steele, Richardson and Olszewski, the clinical spectrum of PSP has expanded and now includes multiple phenotypic variants linked by a common disease. ...
PURPOSE OF REVIEW: Since the original description of progressive supranuclear palsy (PSP) by Steele, Richardson and Ols …
928 results